Compare Charles River Laboratories Intl. Inc (CRL) vs iShares MSCI Germany (DAX) (EWG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs iShares MSCI Germany (DAX) — how do they compare? Charles River Laboratories Intl. Inc trades at $301.79 (market cap $14.23B), while iShares MSCI Germany (DAX) trades at $40.96 (market cap $1.42B). The key difference: Charles River Laboratories Intl. Inc is far larger — about 10× iShares MSCI Germany (DAX)'s market cap, and Charles River Laboratories Intl. Inc is trading nearer its 52-week high, iShares MSCI Germany (DAX) nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and iShares MSCI Germany (DAX) for 54 Days on average.
| CRL | EWG | |
|---|---|---|
Market Cap | $14.23B | $1.42B |
Volume | 1,176,885 | 1,110,573 |
Sector | Health | Broad Market / Factor |
52-Week High | $310.77 | $44.59 |
52-Week Low | $149.93 | $38.08 |
Typical Hold Time | 33 Days | 54 Days |
Enterprise Value | $17.06B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $298.00, down 0.77% on the day, with a bullish technical signal supported by moving averages. The company has beaten earnings estimates for three consecutive quarters, though it reported a net loss of -$144.34M for 2025. Analyst consensus is strongly positive with a $305.50 price target, and recent news highlights a strategic growth plan targeting 5%-7% revenue growth by 2030.
The stock's outlook is supported by strong analyst buy ratings and a clear growth strategy, but faces risks from negative profitability metrics and high valuation multiples. Investment opportunity hinges on successful execution of margin expansion and cost savings initiatives, while key risks include persistent net losses and competitive pressures in the healthcare services sector.
EWG is trading at $40.67, down 0.59% with a bearish technical outlook as 19 indicators signal sell versus only 3 buy signals. The stock faces strong downward pressure with all moving averages in bearish alignment, though RSI readings below 30 suggest potential oversold conditions. Recent European market sentiment is mixed with ECB rate hikes and energy price concerns creating headwinds for European-focused investments.
The bearish technical setup and European macroeconomic uncertainty present near-term challenges, though oversold RSI levels may offer tactical opportunities. Investors should monitor ECB policy decisions and energy price stability as key catalysts for directional moves in this European market exposure vehicle.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About iShares MSCI Germany (DAX)
EWG is a country-specific ETF that tracks the performance of the German equity market. It provides exposure to large and mid-sized companies in Germany across key sectors like industrials and financials, with top holdings such as SAP, Siemens, and Allianz.
Read more on EWG →
